NASDAQ:LXRX
Lexicon Pharmaceuticals, Inc.
- Stock
Last Close
1.43
06/11 22:31
Market Cap
589.23M
Beta: 1.33
Volume Today
4.08M
Avg: 593.73K
PE Ratio
−3.21
PFCF: −3.75
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 2.38M - | 2.38M 0% | 974K - | 3.31M 240.25% | 4.46M 34.63% | 2.12M 52.45% | |||||
average payables | 11.39M - | 16.39M 43.94% | 36.30M 121.42% | 55.26M 52.24% | 37.71M 31.77% | 14.97M 60.30% | 8.82M 41.05% | 7.31M 17.15% | 9.77M 33.69% | ||
average receivables | 912.50K - | 973K 6.63% | 4.20M 331.81% | 6.16M 46.58% | 5.37M 12.73% | 31.23M 481.04% | 28.46M 8.85% | 204.50K 99.28% | 21K 89.73% | ||
book value per share | 3.72 - | 2.76 25.82% | 1.52 45.08% | 0.50 67.33% | -13.91 2,908.59% | -12.63 9.18% | 1.41 111.17% | -10.21 824.04% | -9.59 6.09% | ||
capex per share | -0.00 - | -0.01 738.35% | -0.00 74.68% | -0.00 2.59% | -0.00 58.57% | -0.00 26.58% | -0.00 19.10% | -0.01 968.02% | -0.01 4.56% | ||
capex to depreciation | -0.04 - | -1.25 2,916.64% | -0.11 91.02% | -0.07 40.30% | -0.03 61.55% | -0.02 25.73% | -0.03 54.79% | -4.18 14,001.77% | -3.11 25.74% | ||
capex to operating cash flow | 0.00 - | -0.00 565.54% | 0.00 126.71% | 0.00 6.50% | 0.00 48.02% | -0.00 196.22% | 0.00 198.93% | 0.01 2,205.87% | 0.01 6.36% | ||
capex to revenue | -0.00 - | -0.01 99.95% | -0.00 60.40% | -0.00 8.94% | -0.00 40.45% | -0.00 85.54% | -0.00 1,568.23% | -4.10 112,905.84% | -9.54 132.82% | ||
cash per share | 7.09 - | 8.11 14.31% | 6.22 23.22% | 5.32 14.51% | 2.27 57.43% | 2.56 12.91% | 1.37 46.28% | 0.60 56.65% | 0.83 40.18% | ||
days of inventory on hand | 374.42 - | 685.75 83.15% | 479.32 30.10% | ||||||||
days payables outstanding | 11.08K - | 2.60K 76.52% | 1.38K 47.13% | 1.03K 24.78% | |||||||
days sales outstanding | 16.53 - | 2.56 84.53% | 32.81 1,183.01% | 19.50 40.59% | 34.21 75.47% | 64.07 87.29% | 6.01 90.62% | 17.15 185.39% | 73.53 328.78% | ||
debt to assets | 0.23 - | 0.16 29.26% | 0.21 32.00% | 0.56 163.85% | 0.86 53.22% | 0.59 31.62% | 0.06 89.34% | 0.02 73.52% | 0.28 1,609.60% | ||
debt to equity | 0.38 - | 0.37 2.36% | 0.64 74.12% | 4.72 631.59% | -0.17 103.53% | -0.18 10.28% | 0.08 144.62% | -0.00 101.87% | -0.03 2,170.65% | ||
dividend yield | 0.00 - | 0.57 - | 0.02 96.43% | ||||||||
earnings yield | -0.21 - | -0.00 98.35% | -0.10 2,799.51% | -0.12 26.06% | -0.17 38.21% | 0.30 272.09% | -0.19 162.71% | -0.15 16.92% | -0.33 111.81% | -0.52 59.32% | |
enterprise value | 254.66M - | 963.25M 278.25% | 1.19B 23.68% | 974.62M 18.19% | 787.66M 19.18% | 650.98M 17.35% | 265.62M 59.20% | 512.08M 92.79% | 325.50M 36.44% | ||
enterprise value over ebitda | -3.05 - | 83.30 2,833.87% | -8.79 110.55% | -7.35 16.38% | -7.89 7.43% | 3.75 147.54% | -1.51 140.20% | -5.89 290.24% | -3.28 44.26% | ||
ev to operating cash flow | -3.37 - | 5.21 254.80% | -6.78 230.12% | -5.26 22.50% | -5.30 0.82% | 5.72 207.92% | -1.86 132.48% | -5.88 216.75% | -3.66 37.75% | ||
ev to sales | 11.14 - | 7.41 33.51% | 14.30 92.96% | 10.79 24.53% | 12.46 15.50% | 2.02 83.78% | 11.07 447.69% | 1.72K 15,423.11% | 2.34K 36.27% | ||
free cash flow per share | -0.99 - | 1.77 279.01% | -1.69 195.39% | -1.76 4.17% | -1.41 20.34% | 1.07 176.21% | -1.29 220.53% | -0.61 53.06% | -0.54 10.19% | ||
free cash flow yield | -0.16 - | 0.13 185.67% | -0.12 191.81% | -0.18 45.82% | -0.21 18.53% | 0.26 221.93% | -0.38 246.26% | -0.15 59.26% | -0.28 85.27% | ||
graham net net | 4.68 - | 4.55 2.74% | 3.21 29.38% | 1.71 46.76% | -0.61 135.36% | 0.15 124.22% | 0.95 547.38% | 0.44 54.09% | 0.37 15.21% | ||
graham number | 10.49 - | 1.68 84.02% | 6.81 306.77% | 3.70 45.76% | 18.88 410.77% | 18.66 1.16% | 4.48 75.97% | 11.80 163.24% | 11.59 1.81% | ||
income quality | 0.75 - | -39.47 5,334.09% | 1.24 103.15% | 1.44 15.69% | 1.23 14.19% | 0.87 29.06% | 2.44 179.10% | 0.99 59.38% | 0.87 12.10% | ||
intangibles to total assets | 0.21 - | 0.15 28.02% | 0.21 37.68% | 0.22 7.32% | 0.33 50.82% | 0.15 53.83% | 0.22 42.08% | 0.33 48.85% | 0.23 29.54% | 0 100% | |
interest coverage | -44.55 - | 0.22 100.49% | -20.89 9,663.50% | -19.57 6.30% | -4.97 74.60% | 6.84 237.62% | -12.29 279.69% | -108.59 783.38% | -36.24 66.62% | -14.82 59.11% | |
interest debt per share | 1.44 - | 1.09 24.55% | 1.04 4.26% | 2.40 130.85% | 2.51 4.61% | 2.51 0.08% | 0.25 90.18% | 0.02 91.43% | 0.35 1,556.52% | ||
inventory turnover | 0.97 - | 0.53 45.40% | 0.76 43.07% | ||||||||
invested capital | 0.38 - | 0.37 2.36% | 0.64 74.12% | 4.72 631.59% | -0.17 103.53% | -0.18 10.28% | 0.08 144.62% | -0.00 101.87% | -0.03 2,170.65% | ||
market cap | 486.33M - | 1.38B 183.51% | 1.44B 4.18% | 1.04B 27.62% | 702.71M 32.41% | 440.80M 37.27% | 379.08M 14.00% | 573.87M 51.39% | 316.55M 44.84% | 338.33M 6.88% | |
net current asset value | 181.63M - | 163.42M 10.03% | 39.65M 75.74% | -62.44M 257.48% | -137.22M 119.75% | 37.14M 127.07% | 110.30M 196.99% | 65.61M 40.52% | 63.69M 2.92% | ||
net debt to ebitda | 2.77 - | -35.93 1,396.41% | 1.81 105.03% | 0.49 72.84% | -0.85 273.42% | 1.21 242.33% | 0.64 46.81% | 0.71 10.24% | -0.09 112.70% | ||
net income per share | -1.31 - | -0.05 96.56% | -1.36 2,912.79% | -1.23 9.94% | -1.14 7.11% | 1.23 207.56% | -0.63 151.68% | -0.61 4.29% | -0.62 2.68% | -0.79 27.62% | |
operating cash flow per share | -0.99 - | 1.78 280.08% | -1.69 194.80% | -1.76 4.18% | -1.40 20.29% | 1.07 176.30% | -1.29 220.38% | -0.60 53.68% | -0.54 10.26% | ||
payables turnover | 0.03 - | 0.14 325.84% | 0.27 89.15% | 0.35 32.94% | |||||||
receivables turnover | 22.08 - | 142.72 546.32% | 11.12 92.21% | 18.72 68.31% | 10.67 43.01% | 5.70 46.61% | 60.75 966.26% | 21.29 64.96% | 4.96 76.68% | ||
research and ddevelopement to revenue | 3.91 - | 0.73 81.26% | 2.14 191.99% | 1.74 18.80% | 1.59 8.64% | 0.29 82.00% | 6.40 2,143.13% | 184.72 2,785.22% | 379.97 105.70% | 48.91 87.13% | |
return on tangible assets | -0.27 - | -0.01 96.87% | -0.37 4,353.83% | -0.38 1.34% | -0.64 67.68% | 0.37 157.87% | -0.44 219.71% | -0.96 116.83% | -0.69 27.94% | ||
revenue per share | 0.30 - | 1.26 319.28% | 0.80 36.07% | 0.86 6.98% | 0.60 30.42% | 3.03 407.68% | 0.22 92.86% | 0.00 99.05% | 0.00 59.01% | 0.01 549.19% | |
roe | -0.35 - | -0.02 95.36% | -0.90 5,385.77% | -2.48 175.66% | 0.08 103.31% | -0.10 218.42% | -0.45 362.67% | 0.06 113.22% | 0.06 9.34% | ||
roic | -0.26 - | 0.01 103.34% | -0.55 6,496.84% | -0.42 23.55% | 0.09 120.73% | -0.14 256.43% | -1.26 827.77% | 0.06 104.70% | 0.07 12.97% | ||
sales general and administrative to revenue | 0.85 - | 0.18 78.42% | 0.52 181.74% | 0.73 41.89% | 1.01 37.63% | 345.92 - | |||||
shareholders equity per share | 3.72 - | 2.76 25.82% | 1.52 45.08% | 0.50 67.33% | -13.91 2,908.59% | -12.63 9.18% | 1.41 111.17% | -10.21 824.04% | -9.59 6.09% | ||
stock based compensation to revenue | 0.31 - | 0.05 83.01% | 0.09 69.89% | 0.10 17.26% | 0.19 76.47% | 0.04 76.14% | 0.55 1,153.13% | 35.49 6,316.01% | 82.88 133.50% | ||
tangible asset value | 186.12M - | 187.95M 0.98% | 59.50M 68.34% | -44.33M 174.50% | -121.07M 173.13% | 52.84M 143.65% | 111.83M 111.63% | 69.05M 38.25% | 72.58M 5.11% | ||
tangible book value per share | 2.44 - | 1.81 25.57% | 0.57 68.43% | -0.42 173.52% | -1.14 171.60% | 0.50 143.49% | 1.01 102.80% | 0.47 53.01% | 0.44 7.63% | ||
working capital | 324.02M - | 409.40M 26.35% | 193.23M 52.80% | 197.87M 2.40% | 136.57M 30.98% | 272.41M 99.46% | 110.91M 59.28% | 66.80M 39.78% | 117.69M 76.20% |
All numbers in USD (except ratios and percentages)